<DOC>
	<DOC>NCT01588886</DOC>
	<brief_summary>Chronic kidney disease is a severe medical problem in Taiwan public health issue, which the highest incidence and prevalence rate in the world.Proton pump inhibitors may increase the risk of pneumonia appearance, which were caused by profound irreversible gastric acid suppression. The study purpose was to characterize difference of developing pneumonia in chronic kidney disease of prior use proton pump inhibitors.</brief_summary>
	<brief_title>Proton Pump Inhibitor Use is Associated With High Risk of Pneumonia in Chronic Kidney Disease Patients</brief_title>
	<detailed_description>The study used data from Taiwan Health Insurance Research Database; the investigators conducted a population-based cohort study in Taiwan. Case consisted of all patients who had a first diagnosis of chronic kidney disease for the period between 1997 and 2008. The investigators utilized the use of Proton pump inhibitor from chronic kidney disease patients.</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>Chronic kidney disease excluded those patients who had ever been diagnosed with CKD before 1997</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Proton pump inhibitors</keyword>
	<keyword>Pneumonia</keyword>
	<keyword>Retrospective cohort study</keyword>
</DOC>